Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion type Assertion NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_head.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion description "[The expression of PTP4A3/PRL-3 protein was also correlated with advanced cancer stages (P<0.01); this resulted in a significantly poorer prognosis in both overall (P=0.0024) and recurrence-free survival (P=0.0227).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_provenance.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion evidence source_evidence_literature NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_provenance.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion SIO_000772 23064776 NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_provenance.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion wasDerivedFrom befree-20150227 NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_provenance.
- NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_assertion wasGeneratedBy ECO_0000203 NP854903.RAn6wX1Nc2fvlB6N--uYaiVwKDFNjYPXBBPvVgDj3c-WI130_provenance.